Show simple item record

dc.contributor.authorKumar, R
dc.contributor.authorBhosle, J
dc.contributor.authorYap, T
dc.contributor.authorMinchom, A
dc.contributor.authorWalder, D
dc.contributor.authorAli, Z
dc.contributor.authorRatnayake, G
dc.contributor.authorYousaf, N
dc.contributor.authorPopat, S
dc.contributor.authorGunapala, R
dc.contributor.authorO'Brien, M
dc.date.accessioned2018-02-20T14:50:52Z
dc.date.issued2017-01
dc.identifier.citationJournal of Thoracic Oncology, 2017, 12 (1), pp. S1522 - S1522
dc.identifier.issn1556-0864
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1445
dc.identifier.doi10.1016/j.jtho.2016.11.2100
dc.format.extentS1522 - S1522
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.titlePUB129 Optimal Frequency of Tumor Response Evaluation during Palliative Chemotherapy in the Management of Patients with Advanced Thoracic Cancers
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.jtho.2016.11.2100
rioxxterms.licenseref.startdate2017-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJournal of Thoracic Oncology
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume12
pubs.embargo.termsNot known
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record